BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10865197)

  • 1. Cytomegalovirus MHC class I homologues and natural killer cells: an overview.
    Farrell H; Degli-Esposti M; Densley E; Cretney E; Smyth M; Davis-Poynter N
    Microbes Infect; 2000 Apr; 2(5):521-32. PubMed ID: 10865197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus evasion of natural killer cell responses.
    Farrell HE; Degli-Esposti MA; Davis-Poynter NJ
    Immunol Rev; 1999 Apr; 168():187-97. PubMed ID: 10399075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.
    Farrell HE; Vally H; Lynch DM; Fleming P; Shellam GR; Scalzo AA; Davis-Poynter NJ
    Nature; 1997 Apr; 386(6624):510-4. PubMed ID: 9087412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses.
    Kim Y; Park B; Cho S; Shin J; Cho K; Jun Y; Ahn K
    PLoS Pathog; 2008 Aug; 4(8):e1000123. PubMed ID: 18688275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of CMV-encoded MHC class I homologues.
    Farrell HE; Davis-Poynter NJ; Andrews DM; Degli-Esposti MA
    Curr Top Microbiol Immunol; 2002; 269():131-51. PubMed ID: 12224506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog.
    Leong CC; Chapman TL; Bjorkman PJ; Formankova D; Mocarski ES; Phillips JH; Lanier LL
    J Exp Med; 1998 May; 187(10):1681-7. PubMed ID: 9584146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells.
    Reyburn HT; Mandelboim O; Valés-Gómez M; Davis DM; Pazmany L; Strominger JL
    Nature; 1997 Apr; 386(6624):514-7. PubMed ID: 9087413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome.
    Pyzik M; Kielczewska A; Vidal SM
    Semin Immunol; 2008 Dec; 20(6):331-42. PubMed ID: 18948016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions.
    Sutherland CL; Chalupny NJ; Cosman D
    Immunol Rev; 2001 Jun; 181():185-92. PubMed ID: 11513139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.
    Cosman D; Müllberg J; Sutherland CL; Chin W; Armitage R; Fanslow W; Kubin M; Chalupny NJ
    Immunity; 2001 Feb; 14(2):123-33. PubMed ID: 11239445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.
    López-Botet M; Angulo A; Gumá M
    Tissue Antigens; 2004 Mar; 63(3):195-203. PubMed ID: 14989708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance.
    Revilleza MJ; Wang R; Mans J; Hong M; Natarajan K; Margulies DH
    J Biomed Biotechnol; 2011; 2011():724607. PubMed ID: 21765638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mimicry by cytomegaloviruses. Function of cytomegalovirus-encoded homologues of G protein-coupled receptors, MHC class I heavy chains and chemokines.
    Vink C; Beisser PS; Bruggeman CA
    Intervirology; 1999; 42(5-6):342-9. PubMed ID: 10702716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of HLA expression in human cytomegalovirus immune evasion.
    Lin A; Xu H; Yan W
    Cell Mol Immunol; 2007 Apr; 4(2):91-8. PubMed ID: 17484802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus and natural killer-mediated surveillance of HLA class I expression: a paradigm of host-pathogen adaptation.
    López-Botet M; Llano M; Ortega M
    Immunol Rev; 2001 Jun; 181():193-202. PubMed ID: 11513140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?
    Halenius A; Gerke C; Hengel H
    Cell Mol Immunol; 2015 Mar; 12(2):139-53. PubMed ID: 25418469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK recognition of cytomegalovirus-infected endothelial cells depends on viral replication and MHC class I expression.
    Weinberg A; Zhang L; Tuder RM
    Viral Immunol; 1996; 9(2):131-40. PubMed ID: 8822629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer.
    Cerwenka A; Lanier LL
    Tissue Antigens; 2003 May; 61(5):335-43. PubMed ID: 12753652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.
    Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH
    Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral evasion of natural killer cells during human cytomegalovirus infection.
    Braud VM; Tomasec P; Wilkinson GW
    Curr Top Microbiol Immunol; 2002; 269():117-29. PubMed ID: 12224505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.